Chengtian Technology Launches KidGo: China's First NMPA-Cleared Pediatric Exoskeleton for Neurological Rehabilitation
RoboCT
Exoskeleton Robot and Its Core Component R&D Provider
According to literature such as the “Meta-analysis of the Prevalence of Cerebral Palsy in Children Aged 0–6 Years in China,” the “Expert Consensus on Quality Control Management of Pediatric Rehabilitation in China,” and the “Epidemiological Characteristics of Pediatric Cerebral Palsy in Twelve Provinces and Cities of China,” the international prevalence of cerebral palsy in children is 0.20%–0.35%. There are currently 6 million individuals with cerebral palsy in China, with 40,000–50,000 new cases added annually. Moreover,Shortage of Pediatric Rehabilitation Resources, with varying levels of diagnostic and treatment proficiency among healthcare institutions and personnel, nearly 19.9% of pediatric patients failed to receive timely diagnosis and treatment locally.
Given that 40% of children with cerebral palsy are unable to walk independently, traditional gait training therapies often fail to achieve optimal outcomes; furthermore, the lack of effective, specialized assistive devices increases the difficulty of implementing early walking interventions for pediatric patients.
To address the aforementioned issues, byHangzhou RoboCT Technology Development Co., Ltd.(hereinafter referred to as “RoboCT”) developed byThe KidGo series of pediatric exoskeletons, covering 11 models, in October 2023Approved NMPA Class II Medical Device Registration Certificate (Zhejiang Medical Device Registration No. 20232191770), specifically designed forChildren with lower limb motor dysfunction caused by central nervous system disorders such as cerebral palsy, traumatic brain injury, spinal cord injury, and muscular weaknessDesigned to provide comprehensive rehabilitation support for pediatric users, helping them cultivate a positive and optimistic mindset toward recovery.
On Wednesday, August 28, at 19:30, the 89th session of VCBeat New Product Showcase will feature Fu Xiaohu, Chief Therapist of the Department of Rehabilitation at Beijing Children’s Hospital (National Center for Children’s Health, Capital Medical University); Zhang Guorui, Marketing Director of RoboCT; and Ao Han, Medical Manager of RoboCT, who will present “AllChina’s First Pediatric Exoskeleton Product, Tongxing KidGo, to Obtain NMPA Class II Medical Device Registration Certificate” sharing and introduction.
KidGo Pediatric Rehabilitation Exoskeleton Solution
Tongxing KidGo Pediatric ExoskeletonThe underlying core technology has been upgraded toIntent Detection Technology, by fusing multi-sensor information, it monitors human-robot interaction torque in real time, rapidly and accurately identifies the user’s walking intent, and responds with appropriate gait adjustments. The KidGo series of pediatric exoskeletons by RoboCT has not only passedHoist load, pulley load, pressure resistance test, and drive module, etc.Comprehensive quality and safety testing and inspection, as well asHandwheel torque, battery insertion force, ankle torsional force, etc.Standardization and testing were conducted for multiple non-mandatory requirement details.
Tongxing KidGo Pediatric Rehabilitation ExoskeletonBy providing repetitive and correct movement training, the bottom-up facilitation of neural control circuits enables children’s developing brains and motor systems to relearn and adapt to normal movement patterns. Through multimodal gait training setups, walking training is no longer merely the repetition of simple mechanical movements, but ratherIntelligent, Purposeful Training Stimulation。
With the KidGo series of pediatric exoskeletons fully entering the rehabilitation market, it willPediatric RehabilitationBringing Breakthrough Progress. Pediatric ExoskeletonsGreater Emphasis on Walking Assistance and Gait Correction, with the frequency and intensity of each training session optimized by algorithms to maximize rehabilitation outcomes.It is worth mentioning that the advantage of exoskeleton robots lies in their ability toStandardization of Rehabilitation Occupational Therapy, enabling primary care and community-based rehabilitation institutions to achieve a high level of rehabilitative therapy;Expanding the Effective Coverage of Medical Resources. Pediatric exoskeletons can also perform tasks for extended periods, significantlyReduces repetitive tasks for rehabilitation therapists, while improving the work efficiency of rehabilitation therapists, reduce the complete reliance on them in traditional rehabilitation training.
Scan the QR code on the poster to add the assistant and schedule the live stream.
Fu Xiaohu
Chief Therapist, Department of Rehabilitation Medicine, Beijing Children's Hospital, Capital Medical University (National Center for Children's Health)
Graduated with a major in Rehabilitation Therapy from Capital Medical University. Serves as a Committee Member of the Physical Therapy Professional Committee of the Chinese Association of Rehabilitation Medicine and as a Committee Member of the Pediatric Professional Committee of the Beijing Association of Rehabilitation Medicine. Has participated in multiple clinical trial projects for Pfizer, Novartis, and Biogen. Contributed to the research project “Study on the Construction of a Scientific Rehabilitation System for Children with Cerebral Palsy” conducted by the Hospital Management Institute of the National Health and Family Planning Commission. Holds numerous professional certifications, including the International Bobath Concept Training Course, International Good Clinical Practice (GCP) for Neuromuscular Diseases, International GCP for Lokomat Rehabilitation Robotics, and Certified Physical Therapist training in China. Closely monitors the latest developments in medical technologies and therapeutic approaches both domestically and internationally.
Zhang Guorui
Marketing Director, RoboCT
With years of experience in the medical rehabilitation sector, I possess keen market insights and extensive expertise. As Marketing Director at RoboCT, I played a pivotal role in the development of rehabilitation exoskeleton products and the formulation of marketing strategies. Prioritizing communication and collaboration with medical institutions, research institutes, and end-users, I helped establish a strong industry reputation for the company. This contributed to the deployment of RoboCT’s rehabilitation exoskeleton devices in over 700 rehabilitation centers, disabled persons’ federation agencies, and hospitals across China, covering more than 92% of provincial-level administrative regions and serving over 400,000 individuals cumulatively.
Aohan
Medical Department Manager, RoboCT
Graduated from Nanjing University of Chinese Medicine, with over 10 years of experience in clinical neurological rehabilitation. Specializes in the research design and clinical application of AI-integrated technologies, including bedside exoskeleton robots and pediatric sensory integration training systems. Participated in one National Major Science and Technology Project and two Zhejiang Provincial Major Projects, dedicated to continuously exploring new technologies and methods to enhance product performance and functionality. Through clinical research and technology promotion, has facilitated over 250 clinical rehabilitation cases using robotic systems, providing higher-quality treatment and rehabilitation services for patients and children.
About RoboCT
Hangzhou RoboCT Technology Development Co., Ltd., established in 2017, is a national high-tech enterprise driven by technological innovation. Dedicated to the research, development, and application of exoskeleton robot technologies, including core algorithms and key components, the company currently focuses on the fields of rehabilitation and elderly care. By integrating human-computer interaction, artificial intelligence, data analytics, and cloud computing, it provides intelligent products and solutions for medical and wellness institutions as well as individual users. Committed to benefiting individuals with motor impairments caused by neurological injuries and those with mobility limitations, the company aims to enhance human physical capabilities through robotics. It seeks to expand the application of exoskeleton technology across health, industrial, safety, transportation, and entertainment sectors, striving to realize the vision of “Human Plus” and ultimately enabling everyone to benefit from robotic services.
RoboCT’s independently developed and manufactured portfolio of five series of rehabilitation exoskeleton products has all obtained NMPA registration certificates for exoskeleton robots indicated for central nervous system disorders, filling a gap in the domestic market. RoboCT possesses full-chain core technologies for exoskeleton robots, including motors, reducers, joint modules, sensors, and core algorithms. The company has filed over 500 independent intellectual property rights and won more than 40 international awards, including prestigious industrial design honors such as the Red Dot, Hongxing, iF, and DIA awards. It has successively achieved certifications under various professional systems, including CE, ISO 13485, ISO 9001, ISO 45001, ISO 14001, ISO 27001, and an intellectual property management system.
VCBeat New Product Review
“VCBeat New Product Showcase” is a live-streaming program designed to support healthcare companies in launching their innovative products. The program’s mission is to facilitate the milestone launch of every innovative medical product. Companies with plans to release innovative medical products or achieve significant milestones and wish to participate in the “VCBeat New Product Showcase” are invited to add our assistant for consultation.
Method 1: Watch the live stream via the Mini Program
Scan the QR code below to contact the assistant and reserve a spot for the live broadcast (if you have already added them, please reach out to the assistant directly).
Option 2: Watch the live stream on the VCBeat app for a chance to win exciting prizes.
Scan the QR code below to download the VCBeat app and register to watch the live stream.
Contact the assistant and send a screenshot of the live stream to enter the lucky draw for a chance to win a [15-day trial membership of VBInsight Industry Think Tank].
